Objective The TRANSVAC infrastructure will accelerate the pharmaceutical and clinical development of promising vaccine candidates by bringing the gap between academic research and clinical trials through carefully managing the advancement of promising vaccine candidates from preclinical animal models to early proof-of-principle studies in humans. Although expertise already exists within Europe spanning different disease types, there is currently very limited coordination between vaccine R&D groups, assay developers and vaccine producers. Unarguably, fragmentation of expertise and facilities has slowed, and in some instances distinctly impeded, the development and validation of promising vaccine candidates. To address these challenges the European vaccine development community needs to establish a collaborative vaccine development infrastructure based on shared visions and goals. The European Vaccine Initiative (EVI) and the Tuberculosis Vaccine Integrated (TBVI) Project have each demonstrated significant success in creating the know-how and infrastructures to enable the advancement of European vaccine development. In order to sustain the momentum generated by EVI and TBVI these successes will be built-upon to create an infrastructure driven by EVI, in which all stakeholders commit to sharing facilities and knowhow on vaccine development. This consortium (TRANSVAC) will comprise major European stakeholders with expertise, resources and facilities for each stage of vaccine development, from the scientific community as well as vaccine developers. Each stakeholder can add to what EVI and TBVI have already established by adding their own expertise to the TRANSVAC long term strategy. TRANSVAC will be the European driving force for vaccine development, and will be accessible to any interested parties. This consortium will initiate a new era in the innovative, harmonised and rapid development of accessible and efficacious vaccines for Europe and the rest of the world. Fields of science medical and health sciencesclinical medicinepneumologytuberculosismedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines Programme(s) FP7-INFRASTRUCTURES - Specific Programme "Capacities": Research infrastructures Topic(s) INFRA-2008-1.1.2 - Targeted approach: Integrated Activities to support the specific needs of thematic priority areas Call for proposal FP7-INFRASTRUCTURES-2008-1 See other projects for this call Funding Scheme CP-CSA-Infra - Combination of CP and CSA Coordinator EUROPEAN VACCINE INITIATIVE EWIV EU contribution € 2 116 215,72 Address VOSSSTRASSE 2 GEB 4040 69115 Heidelberg Germany See on map Region Baden-Württemberg Karlsruhe Heidelberg, Stadtkreis Activity type Research Organisations Administrative Contact Odile Leroy (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Participants (14) Sort alphabetically Sort by EU Contribution Expand all Collapse all STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER Netherlands EU contribution € 1 404 380,36 Address LANGE KLEIWEG 161 2288 GJ Rijswijk Zh See on map Region West-Nederland Zuid-Holland Agglomeratie ’s-Gravenhage Activity type Research Organisations Administrative Contact Willem Slingerland (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH Germany EU contribution € 577 460,33 Address INHOFFENSTRASSE 7 38124 Braunschweig See on map Region Niedersachsen Braunschweig Braunschweig, Kreisfreie Stadt Activity type Research Organisations Administrative Contact Michael Straetz (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Serum Life Science Europe GmbH Germany EU contribution € 23 100,00 Address Ahrensburger Straße 1 30659 HANNOVER See on map Region Niedersachsen Hannover Region Hannover Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Leander Grode (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data LIONEX GMBH Germany EU contribution € 959 975,00 Address Salzdahlumer Strasse 196 38126 Braunschweig See on map Region Niedersachsen Braunschweig Braunschweig, Kreisfreie Stadt Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Mahavir Singh (Prof.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data ID-LELYSTAD, INSTITUUT VOOR DIERHOUDERIJ EN DIERGEZONDHEID B.V. Participation ended Netherlands EU contribution € 86 615,36 Address Edelhertweg 15 8219PH LELYSTAD See on map Activity type Research Organisations Administrative Contact Jelle Thole (Dr.) Links Contact the organisation Opens in new window Total cost No data HEALTH PROTECTION AGENCY HPA United Kingdom EU contribution No data Address BUCKINGHAM PALACE ROAD 151 SW1W 9SZ London See on map Activity type Research Organisations Administrative Contact Steve White (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV Germany EU contribution € 979 494,97 Address HOFGARTENSTRASSE 8 80539 Munchen See on map Region Bayern Oberbayern München, Kreisfreie Stadt Activity type Research Organisations Administrative Contact Stefan H.E. Kaufmann (Prof.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data UNIVERSITAET REGENSBURG Germany EU contribution € 229 006,82 Address UNIVERSITATSSTRASSE 31 93053 Regensburg See on map Region Bayern Oberpfalz Regensburg, Kreisfreie Stadt Activity type Higher or Secondary Education Establishments Administrative Contact Christian Blomeyer (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER United Kingdom EU contribution € 339 000,00 Address KEPPEL STREET WC1E 7HT London See on map Region London Inner London — West Camden and City of London Activity type Higher or Secondary Education Establishments Administrative Contact Penny Ireland (Ms.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD United Kingdom EU contribution € 900 495,00 Address WELLINGTON SQUARE UNIVERSITY OFFICES OX1 2JD Oxford See on map Region South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire Activity type Higher or Secondary Education Establishments Administrative Contact Gary Strickland (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data UNIVERSITE DE LAUSANNE Switzerland EU contribution € 656 775,56 Address QUARTIER UNIL CENTRE - BATIMENT UNICENTRE 1015 LAUSANNE See on map Region Schweiz/Suisse/Svizzera Région lémanique Vaud Activity type Higher or Secondary Education Establishments Administrative Contact Gerard Mareine (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data STICHTING TUBERCULOSIS VACCINE INITIATIVE Netherlands EU contribution € 85 107,28 Address Runderweg 6 8219 PK LELYSTAD See on map Region Oost-Nederland Flevoland Flevoland Activity type Other Administrative Contact Jelle Thole (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data STICHTING WAGENINGEN RESEARCH Netherlands EU contribution € 586 018,06 Address DROEVENDAALSESTEEG 4 6708 PB Wageningen See on map Region Oost-Nederland Gelderland Veluwe Activity type Research Organisations Administrative Contact Norbert Stockhofe (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Department of Health United Kingdom EU contribution € 956 354,54 Address Quarry House, Quarry Hill LS2 7UE Leeds See on map Region Yorkshire and the Humber West Yorkshire Leeds Activity type Research Organisations Administrative Contact Cathy Rowe (Mrs.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data
